Courtney Breen
Stock Analyst at Bernstein
(4.51)
# 1,062
Out of 4,651 analysts
301
Total ratings
89.1%
Success rate
19.7%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Courtney Breen
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| LLY Eli Lilly and Company | Maintained: Buy | $1,385 | $1,180.16 | +17.36% | 61 | Aug 6, 2026 | |
| AMGN Amgen | Maintained: Hold | $335 → $345 | $415.21 | -16.91% | 31 | Aug 5, 2026 | |
| BMY Bristol-Myers Squibb Company | Maintained: Hold | $58 | $63.83 | -9.13% | 31 | Jul 22, 2026 | |
| GILD Gilead Sciences | Maintained: Buy | $160 | $138.36 | +15.64% | 30 | Jul 22, 2026 | |
| MRK Merck & Co. | Maintained: Hold | $100 | $135.84 | -26.38% | 39 | Jul 22, 2026 | |
| PFE Pfizer | Maintained: Hold | $30 | $26.79 | +11.98% | 38 | Jul 22, 2026 | |
| ABBV AbbVie | Maintained: Hold | $225 | $249.46 | -9.81% | 29 | Jul 22, 2026 | |
| MRNA Moderna | Maintained: Hold | $45 | $63.32 | -28.93% | 41 | Jul 22, 2026 | |
| LON: 0QIU Novo Nordisk A/S | Maintained: Sell | kr 175.00 | kr 294.70 | -40.62% | 1 | May 12, 2026 |
Eli Lilly and Company
Aug 6, 2026
Maintained: Buy
Price Target: $1,385
Current: $1,180.16
Upside: +17.36%
Amgen
Aug 5, 2026
Maintained: Hold
Price Target: $335 → $345
Current: $415.21
Upside: -16.91%
Bristol-Myers Squibb Company
Jul 22, 2026
Maintained: Hold
Price Target: $58
Current: $63.83
Upside: -9.13%
Gilead Sciences
Jul 22, 2026
Maintained: Buy
Price Target: $160
Current: $138.36
Upside: +15.64%
Merck & Co.
Jul 22, 2026
Maintained: Hold
Price Target: $100
Current: $135.84
Upside: -26.38%
Pfizer
Jul 22, 2026
Maintained: Hold
Price Target: $30
Current: $26.79
Upside: +11.98%
AbbVie
Jul 22, 2026
Maintained: Hold
Price Target: $225
Current: $249.46
Upside: -9.81%
Moderna
Jul 22, 2026
Maintained: Hold
Price Target: $45
Current: $63.32
Upside: -28.93%
Novo Nordisk A/S
May 12, 2026
Maintained: Sell
Price Target: kr 175.00
Current: kr 294.70
Upside: -40.62%